Top Markets
Coin of the day
Anthera Pharmaceuticals, Inc. Anthera Pharmaceuticals, Inc.

Anthera Pharmaceuticals, Inc.

ANTH
Rankning i aktier #42276
Anthera Pharmaceuticals, Inc., a biopharmaceutical enterprise, concentrates on... Anthera Pharmaceuticals, Inc., a biopharmaceutical enterprise, concentrates on developing and commercializing therapeutic solutions for conditions with significant unmet medical needs. The company's pipeline includes Sollpura, an investigational non-porcine pancreatic enzyme replacement therapy in Phase III clinical trials for individuals with exocrine pancreatic insufficiency. It is also advancing Blisibimod, currently in Phase II clinical evaluation for B-cell mediated autoimmune diseases, such as immunoglobulin A nephropathy (IgA nephropathy). Anthera holds licensing agreements with Amgen, Inc. and Eli Lilly and Company. Founded in 2004, the company's base of operations is in Houston, Texas.
Aktiekurs
$0.0001
Senast synkroniserad: 2026-08-11
Marknadsvärde
$2.62K
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel Anthera Pharmaceuticals, Inc. (ANTH)

Kategori

Historik för aktiesplit för Anthera Pharmaceuticals, Inc. (ANTH)
Aktien Anthera Pharmaceuticals, Inc. (symbol: ANTH) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 12, 2026.
En ANTH-aktie köpt före Aug 12, 2026 motsvarar nu 0 ANTH-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR